Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Completed 24Unknown 6Recruiting 6Terminated 5Withdrawn 4Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Sarcoma 1Head & Neck 1Dermatologic 1Breast 1

Conditions

Uveal Neoplasms 1Uveal Melanoma 1Thyroid Neoplasms 1Sarcoma, Ewing 1Neoplasm Metastasis 1Melanoma 1Iris Neoplasms 1Choroid Neoplasms 1Breast Neoplasms 1

Interventions

Cyclophosphamide 129Cisplatin 119Radiotherapy 115pembrolizumab 111Carboplatin 97Paclitaxel 96Gemcitabine 96Magnetic Resonance Spectroscopy 80Nivolumab 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Biopsy 53Doxorubicin 52fludarabine 51Drug Therapy 45durvalumab 44Cytarabine 44Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Surveys and Questionnaires 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Withdrawn × Biopsy, Fine-Needle × Clear all
NCT05042934 2022-02-10

Lurbinectedin With or Without Irinotecan in Treating Patients With Relapsed or High Risk Metastatic Ewing Sarcoma

M.D. Anderson Cancer Center

Phase 1/2 Withdrawn
Sarcoma

Sarcoma, Ewing

NCT00329017 2019-10-10

Protocol for Postmenopausal Women at Increased Risk of Developing Breast Cancer

University of Kansas Medical Center

Withdrawn
Breast

Breast Neoplasms

NCT00406120 2018-06-26

Validation of a Molecular Prognostic Test for Eye Melanoma

Washington University School of Medicine

Withdrawn
Dermatologic

Uveal Melanoma, Choroid Neoplasms, Melanoma, Neoplasm Metastasis, Uveal Neoplasms, Iris Neoplasms

NCT00954837 2013-05-27

CYT2THYR

Assistance Publique - Hôpitaux de Paris

Phase NA Withdrawn
Head & Neck

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡